FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA OKs PharmaThers Ketamine for Surgical Pain

FDA approves PharmaThers KETARx (ketamine), indicated for use in treating surgical pain.

Biologics

FDA Orders Stricter Safety Labeling for Skysona

FDA orders significant labeling changes for Bluebird Bios Skysona (elivaldogene autotemcel), a gene therapy approved for treating early, active cerebr...

latest-news-card-1
Human Drugs

Sodium Chloride Drug Shortage Resolved: Makary

FDA says a nationwide shortage of sodium chloride 0.9% injection products has officially ended.

Medical Devices

BD Recalls BD Alaris Pump Software

Becton Dickinson recalls (Class 1 device correction) its BD Alaris Pump Module Model 8100 with Guardrails, Suite MX software versions.

latest-news-card-1
Human Drugs

Accelerated OK for Boehringer Lung Cancer Drug

FDA grants Boehringer Ingelheim accelerated approval for Hernexeos (zongertinib), a kinase inhibitor for treating certain adults with unresectable or ...

latest-news-card-1
Human Drugs

FDA Ramps Up Global Drug Quality Oversight

FDA expands its drug quality enforcement efforts since the end of the Covid-19 Public Health Emergency, with foreign oversight reaching all-time highs...

latest-news-card-1
Human Drugs

Valneva Chikungunya OK to Use Again: FDA

FDA lifts an earlier recommended pause on the use of Valnevas Ixchiq vaccine for chikungunya virus.

latest-news-card-1
Human Drugs

FDA Steps to Boost U.S. Drug Production

FDA says it is starting the FDA PreCheck program to help drug companies develop manufacturing facilities in the U.S.

Human Drugs

FibroGen, FDA Agree on Roxadustat Phase 3 Elements

FDA and FibroGen reach an agreement on key elements in a Phase 3 trial of the companys roxadustat to treat some chemotherapy-induced anemias.

latest-news-card-1
Human Drugs

ICH Extractables, Leachables Guide

FDA publishes a draft International Council on Harmonization guideline for extractables and leachables to solicit public comment.